DSIJ Mindshare

Don’t miss the action in this pharmaceutical stock: The Cup and handle pattern breakout is seen with huge volumes!

Notably, the RSI has entered a super bullish territory, indicating a significant shift in momentum.

DSIJ Intelligence-3 0 1709 Article rating: 4.7

The Nifty Pharmaceutical index has surged by an impressive 30 per cent on a year-to-date basis in 2023, significantly outperforming the Nifty 50 index. Against the backdrop of India experiencing a single-day spike of 628 new COVID-19 cases

1,550 per cent returns and Rs 2,145 crore order book: This multibagger transformer manufacturer bags multiple new orders worth Rs 574 crore!

Shares of the company have gained more than 200 per cent on a YTD basis.

DSIJ Intelligence 0 1963 Article rating: 3.8

Shares of the company have gained more than 200 per cent on a YTD basis.

50 per cent from its 52-week low: This micro-cap company receives an order worth Rs 9,00,000 from Hindustan Petroleum Corporation Ltd; scrip hit upper circuit!

The stock has an ROE of 65.7 per cent and a ROCE of 58.4 per cent.

DSIJ Intelligence-1 0 18218 Article rating: 4.4

The stock is up over 50 per cent from its 52-week low of Rs 203 per share

RSS
First26342635263626372639264126422643Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR